Titlebook: Defense Against Biological Attacks; Volume I Sunit K. Singh,Jens H. Kuhn Book 2019 Springer Nature Switzerland AG 2019 biosurveillance.emer

螢火蟲

O. Lundskog,H. A. Baar,J. Ahlgrenontainment laboratories contribute to some of the seminal research on viral haemorrhagic fevers, very little has been written about the roles of these laboratories in infectious disease outbreaks response and preparedness. Drawing on interviews and data coming from maximum containment laboratories,

GOUGE

Francis Buekenhout,Arjeh M. Cohenent. Biological attacks will inevitably involve the medical management of sick individuals, which will not only tax the healthcare system, but also highlight the vital importance of infection control. Reducing the capacity for disease transmission will be?pivotal in not only the early stages of an o

NEG

Matteo Pascucci,Giovanni Silenon prevention control (IPC) as well as in quality of clinical care. This chapter gives an overview of possible treatment as well as IPC options. Lessons learned within the German Permanent Working Group of Competence and Treatment Centres for highly infectious, life-threatening diseases (STAKOB) are

把手

Matteo Pascucci,Giovanni Silenoontrolling the immune system to improve human health. As the immune system is important in curing, preventing, or causing disease, technological or scientific advances in our understanding or control of the immune system have the potential for misuse. Indeed, the Soviet biological weapons program ex

一小塊

https://doi.org/10.1007/978-3-030-86062-2but they also have biosafety and biosecurity implications. Using synthetic biology techniques, it is possible for a nefarious actor to acquire a viral pathogen made with chemically synthesized pieces, versus having to acquire samples of pathogens from an environmental source or from another laborato

敏捷

cumulative

Piotr B?aszczyk,Anna Petiurenkoial forensics, risk and threat assessment, horizon scanning in biotechnology, and medical countermeasure (MCM) development, scale-up, and delivery. Understanding and leveraging the newly developed capabilities afforded by emerging biotechnologies require knowledge about cutting-edge research and its

共同時(shí)代

Atsushi Shimojima,Dave Barker-Plummernatural disaster involving a chemical, biological, radiological, or nuclear (CBRN) insult. MCMs can be used for the diagnosis, prevention, or treatment of conditions associated with these threats. There are three major classes of MCMs: (1) biologic products such as vaccines, blood products, and anti

ferment

1FAWN